A new medication is under development that aims to be a safer and more effective way to manage multiple sclerosis symptoms..
A new drug to tackle the side effects of multiple sclerosis (MS) will be safer and more effective than current approaches, its West Australian developers say.
MS is a life-long chronic inflammatory and degenerative disorder of the central nervous system that impacts 23,000 Australians and more than two million worldwide.
The inflammation causes lesions in the covering that protects the nerves fibres in the brain, affecting movement capability.
There is currently no cure for MS.
Dr Rakesh Veedu from Murdoch University’s Centre for Comparative Genomics said it was a research priority to find for a treatment for chronic inflammation to ease suffering.
Along with Professor Steve Wilton, Dr Veedu is developing a new drug and drug delivery method to treat inflammation in a more targeted manner.
“One particular protein plays a crucial role in inflammation. So in our research we are developing an innovative DNA enzyme that prevents high levels of this protein to tackle the inflammation,” Dr Veedu said.
“Once we develop this DNA enzyme, we can then attach it with another molecule that is specifically designed to target the correct cells.”
|Read Full Article: New drug to reduce multiple sclerosis side effects being developed – ABC News (Australian Broadcasting Corporation)|